Debbie Feinstein heads Arnold & Porter's Global Antitrust group, and brings a wealth of experience to her practice in advising clients on a range of antitrust challenges before US antitrust authorities. She re-joined the firm from the US Federal Trade Commission (FTC), where she was Director of the Bureau of Competition. In that capacity, she was responsible for supervising the investigation and enforcement of the US antitrust laws against anticompetitive mergers and conduct. During her tenure from 2013 to 2017, the FTC had substantial litigation success and a number of major merger wins, including challenges to Sysco Corp.'s acquisition of rival US Foods Inc., and Staples Inc.'s merger with Office Depot Inc. She had previously served at the FTC from 1989 to 1991 as Assistant to the Director of the Bureau of Competition and Attorney Advisor.

Throughout her career, Ms. Feinstein has focused on merger and acquisition reviews by antitrust enforcement agencies in the United States and globally, as well as civil investigations and litigation. Her industry experience is broad, and includes retail, food, consumer products, healthcare, chemicals, and automotive parts, among others.

Ms. Feinstein has been consistently lauded as a leading practitioner by Chambers USA and other ranking publications. The National Law Journal named her one of the most influential women lawyers in America and Global Competition Review recognized her as global "Lawyer of the Year" and named her to its international list of the "Top 100 Women in Antitrust."


  • Sony in numerous transactions, including its $3.6 billion acquisition of games software developer Bungie and its $2.2 billion acquisition of the music publishing catalogue of EMI.
  • AT&T in the numerous transactions including the merger of the WarnerMedia business with Discovery and its prior acquisition of TimeWarner.
  • Cargill and Continental Grain in their $4.5 billion acquisition of Sanderson Farms.
  • Penguin Random House in its $2.175 billion attempted acquisition of book publisher Simon & Schuster.
  • Thermo Fisher Scientific, Inc. in its $21 billion purchase of PPD Inc.
  • Bristol-Myers Squibb in numerous transactions including its $90 billion acquisition of Celgene and its $4.1 billion acquisition of Turning Point Therapeutics.
  • Pfizer in its $6.7 billion acquisition of Arena Pharmaceuticals.
  • AbbVie in its $63 billion dollar acquisition of Allergan and in its $550 million acquisition of Soliton Inc.
  • Billie in the $310 million sale of its business to Edgewell.
  • Fitbit Inc. in its $2.1 billion sale to Google.
  • Altria in its investment in JLI, the parent company of JUUL.
  • Reyes Holdings in the $2 billion sale of its Reinhart FoodService business to Performance Food Group.
  • Panasonic in establishing Prime Planet Energy & Solutions, Inc., a joint venture with Toyota specializing in automatic prismatic batteries.
  • Cisco Systems, Inc. in its $1.9 billion acquisition of BroadSoft, Inc.
  • Onex and SMG, a facility management company, in its merger with AEG Facilities to create a global facility management and venue services company.
  • Rent-a-Center in its proposed acquisition by Vintage Capital.
  • NxStage Medical, Inc. in connection with its $2 billion sale to Fresenius Medical Care Holdings, Inc.
  • General Electric Co. in numerous transactions including the Comcast/NBCU joint venture, the $4.3 billion acquisition of Avio, and the $2.1 billion acquisition of Instrumentarium.
  • Boston Scientific Corporation in numerous transactions including its $27 billion acquisition of Guidant.
  • Loews Cineplex Entertainment Corporation in its merger with AMC Entertainment Inc.
  • The Kroger Co. in its $13.5 billion merger with Fred Meyer, Inc.
  • Phillip Morris and Kraft in their $18.9 billion acquisition of Nabisco Holdings Corporation, creating the world's largest food company. Negotiations with the FTC resulted in the divestiture of only minimal assets.
  • Occidental Chemical Company in the $360 million purchase of Vulcan Materials Company's chemical assets.
  • PepsiCo in its $14 billion acquisition of The Quaker Oats Company. The merger strengthened PepsiCo's food businesses and added Gatorade, the leading sports drink brand, to its portfolio.
  • Meritor Automotive in its merger with Arvin Industries to become ArvinMeritor, a leading automotive industry supplier.
  • Genzyme's acquisition of Novazyme. The acquisition combined the only two companies performing research and development on a rare disease.
  • Unilever in the acquisition of Alberto Culver and in the sale of its Lawry's & Adolph's spice/seasonings business to McCormick.


Mergers: Return of Monopsony as an Antitrust Concern
GCR Live: Law Leaders Global
Three-Part Webinar Series: Antitrust 2022 Year in Review: Cartel/Criminal Investigations, Litigation and Mergers/Transactions
Arnold & Porter Webinar
FTC Sues to Block Microsoft’s Acquisition of Activision-Blizzard, Challenging a Vertical Transaction in the Video Game Industry
FTC Announces New Guidelines for its Section 5 Enforcement Efforts
PRO In-depth The Pharmaceutical Intellectual Property and Competition Law Review: USA
The Law Reviews


Chambers USA
Antitrust (DC) (2018-2023)
Antitrust (Nationwide) (2022)
Antitrust: Business (2011)
Chambers Global
Competition/Antitrust (USA) (2020–2023)
"Leading Litigator"—Antitrust/Competition, Litigation (2022)
"Leading Lawyers in America" (2006)


  • J.D., Harvard Law School
  • A.B., University of California, Berkeley
  • District of Columbia
Government & Military Service
  • Director of the Bureau of Competition, Federal Trade Commission (2013-2017)
  • Assistant to the Director of the Bureau of Competition and Attorney Advisor, Federal Trade Commission (1989-1991)

Email Disclaimer